C57BL/6NCya-Otud3em1/Cya
Common Name
Otud3-KO
Product ID
S-KO-14093
Backgroud
C57BL/6NCya
Strain ID
KOCMP-73162-Otud3-B6N-VA
When using this mouse strain in a publication, please cite “Otud3-KO Mouse (Catalog S-KO-14093) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Otud3-KO
Strain ID
KOCMP-73162-Otud3-B6N-VA
Gene Name
Product ID
S-KO-14093
Gene Alias
3110030K17Rik
Background
C57BL/6NCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 4
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000097830
NCBI RefSeq
NM_028453
Target Region
Exon 2~3
Size of Effective Region
~4.5 kb
Overview of Gene Research
Otud3, an ovarian-tumor-domain-containing deubiquitinase, is crucial in regulating protein homeostasis by blocking ubiquitin-dependent protein degradation. It is involved in diverse signaling pathways, including those related to immunity, inflammation, metabolism, and cell-cycle regulation [2,3].
Otud3 -/- mice challenged with a high-fat diet developed worse obesity, dyslipidemia, and insulin resistance compared to wild-type mice. This indicates that Otud3 is an important regulator of energy metabolism, with a rare c.863G > A mutation reducing its stability and catalytic activity and being associated with obesity and a higher diabetes risk [1]. In cancer, its role varies. For instance, in breast cancer, deletion of Otud3 in mice promotes tumor development, while in KrasG12D-driven lung adenocarcinoma, in vivo deletion of Otud3 slows down tumor initiation and progression [4]. Also, in liver cancer, Otud3 deficiency in mice leads to enhanced integrated stress response and accelerated tumor progression [5].
In conclusion, Otud3 is a key deubiquitinase with diverse functions. Its role in metabolism is evident from the phenotypes of gene-knockout mouse models in metabolic diseases. In cancer, the use of KO mouse models has shown its context-dependent role as either a tumor suppressor or an oncogene. These findings enhance our understanding of biological processes and disease mechanisms related to Otud3, potentially guiding future therapeutic strategies.
References:
1. Zhou, Na, Qi, Hailong, Liu, Junjun, Song, Yongfeng, Yin, Yuxin. 2022. Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses. In Cell metabolism, 34, 1023-1041.e8. doi:10.1016/j.cmet.2022.05.005. https://pubmed.ncbi.nlm.nih.gov/35675826/
2. Xu, Qiao, He, Lan, Zhang, Shubing, Di, Xiaotang, Jiang, Hao. 2023. Deubiquitinase OTUD3: a double-edged sword in immunity and disease. In Frontiers in cell and developmental biology, 11, 1237530. doi:10.3389/fcell.2023.1237530. https://pubmed.ncbi.nlm.nih.gov/37829187/
3. Hou, Dan, Yu, Dan, Yang, Guoshuai, Hu, Yujie, Li, Hongxin. . Research progress in deubiquitinase OTUD3. In Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 49, 1341-1352. doi:10.11817/j.issn.1672-7347.2024.230581. https://pubmed.ncbi.nlm.nih.gov/39788523/
4. Du, Tongde, Li, Hongchang, Fan, Yongsheng, Han, Chuanchun, Zhang, Lingqiang. 2019. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. In Nature communications, 10, 2914. doi:10.1038/s41467-019-10824-7. https://pubmed.ncbi.nlm.nih.gov/31266968/
5. Dai, Hongmiao, Wu, Bo, Ge, Yingwei, Li, Hongchang, Zhang, Lingqiang. 2024. Deubiquitylase OTUD3 regulates integrated stress response to suppress progression and sorafenib resistance of liver cancer. In Cell reports, 43, 114487. doi:10.1016/j.celrep.2024.114487. https://pubmed.ncbi.nlm.nih.gov/38996071/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
